Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.

類似資料

• Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
  著者:: Lorenzi, A, 等
  出版事項: (2008)
• Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
  著者:: Isaacs, J, 等
  出版事項: (2002)
• Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
  著者:: Isaacs, J, 等
  出版事項: (2004)
• Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
  著者:: Isaacs, J, 等
  出版事項: (2005)
• Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
  著者:: Isaacs, J, 等
  出版事項: (2005)